LOS ANGELES, Feb. 25, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. ( www.MediSwipe.com ) (OTCBB:MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, today announced national coverage as a technology company recently moving to the state of Michigan within the medicinal marijuana sector by the Detroit Free Press, Sunday business edition in both print and online. The full article and interview may be seen by clicking on the following link:
"We are sincerely appreciative that a respected news source such as the Detroit Free Press reached out to our company to learn about our corporate move, intentions and business strategy for the medicinal marijuana sector within the state of Michigan and neighboring states with favorable legislation. They were the first news journal to get it right, and take the necessary time and steps of due diligence to speak to us personally and realize the importance of what we are trying to accomplish and how to further legitimize the industry," stated B. Michael Friedman, CEO of MediSwipe."MediSwipe will seek to provide the first HIPAA compliant medical data management system for the medicinal marijuana sector on behalf of patients and caregivers, providing patient authentication and storage of data, while at the same time streamlining the application process for new patients to receive state ID cards and prescription renewals. Our goal will be to work with all regulated states, caregivers and patients to allow access to a compliant reporting system that will not only ensure patient security and privacy rights, but at the same time, provide necessary reporting data to states to increase state tax revenue as they move to further define individual regulatory models," further stated Friedman. About MediSwipe Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts